Carolyn Botros, DO
Urogynecology and Reconstructive Pelvic Surgery · Bethlehem, PANPI 1003243361
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,073 of the $3,606 with a category attached, or 85.2%. Medtronic accounts for 81.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,146, 4.6 times the $251 reported in 2019.
Across 85 payments — averaging $42.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$442
- Axonics, Inc.$110
- Coloplast$60
- Intuitive Surgical$54
- Avation Medical, Inc.$18
Across 3 payments — averaging $4846.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Provepharm Inc.$14K
- Medtronic$630
What the payments were for
- Travel & lodging$53315%
- Food & beverage$3,07385%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 69 | $2,922 |
| Boston Scientific | 12 | $442 |
| Axonics, Inc. | 1 | $110 |
| Coloplast | 1 | $60 |
| Intuitive Surgical | 1 | $54 |
| Avation Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,606 in reported general payments places this provider in the 60th percentile of 51 urogynecology and reconstructive pelvic surgery providers in Pennsylvania.
See all urogynecology and reconstructive pelvic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 238 | $175,947 |
| MyrbetriqMirabegron | 96 | $67,431 |
| EstringEstradiol | 57 | $30,326 |
| Estradiol | 361 | $24,138 |
| BotoxOnabotulinumtoxina | 11 | $7,567 |
| Mirabegron ErMirabegron | 11 | $4,990 |
| YuvafemEstradiol | 14 | $1,445 |
| Methenamine Hippurate | 14 | $1,218 |
| Trimethoprim | 14 | $819 |
| Hydroxyzine Hcl | 28 | $522 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 44 | $518 |
| Clobetasol Propionate | 12 | $440 |
| Cephalexin | 49 | $277 |
| Triamcinolone Acetonide | 39 | $146 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $66 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Bethlehem
- Vincent LucenteAllentown$798K
- Miles MurphyAllentown$54K
- Heather GottliebNewtown$48K
- Michael BonidieMechanicsburg$39K
- Lily AryaPhiladelphia$34K
- Julie DroletYork$29K
- Alexander BrusckeQuakertown$24K
- Marc TogliaMedia$22K
- Vani DandoluWilkes Barre$22K
- Luis Espaillat RijoLansdale$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.